These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 16755776)
1. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation]. Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776 [TBL] [Abstract][Full Text] [Related]
2. Treatment of febrile neutropenia with cefepime monotherapy. Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793 [TBL] [Abstract][Full Text] [Related]
3. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia. Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102 [TBL] [Abstract][Full Text] [Related]
5. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer. Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors. Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566 [TBL] [Abstract][Full Text] [Related]
7. Cefepime monotherapy for treatment of febrile neutropenia in children. Ariffin H; Ai CL; Lee CL; Abdullah WA J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients. Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896 [TBL] [Abstract][Full Text] [Related]
9. Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial. Engervall P; Kalin M; Dornbusch K; Björkholm M J Chemother; 1999 Aug; 11(4):278-86. PubMed ID: 10465130 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia. Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851 [TBL] [Abstract][Full Text] [Related]
11. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial. Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711 [TBL] [Abstract][Full Text] [Related]
12. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821 [TBL] [Abstract][Full Text] [Related]
13. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor]. Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750 [TBL] [Abstract][Full Text] [Related]
14. Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia. Jimeno A; Arcediano A; Bazares S; Amador ML; González-Cortijo L; Ciruelos E; Robles L; Castellano D; Paz-Ares L; Lumbreras C; Hornedo J; Cortés-Funes H Clin Transl Oncol; 2006 Dec; 8(12):889-95. PubMed ID: 17169762 [TBL] [Abstract][Full Text] [Related]
15. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540 [TBL] [Abstract][Full Text] [Related]
16. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy. Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683 [TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671 [TBL] [Abstract][Full Text] [Related]
19. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H; Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952 [TBL] [Abstract][Full Text] [Related]
20. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). Biron P; Fuhrmann C; Cure H; Viens P; Lefebvre D; Thyss A; Viot M; Soler-Michel P; Rollin C; Grès JJ J Antimicrob Chemother; 1998 Oct; 42(4):511-8. PubMed ID: 9818751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]